ArticleKidney international reports2025

Obinutuzumab and Ofatumumab are More Effective Than Rituximab in the Treatment of Membranous Nephropathy Patients With Anti-Rituximab Antibodies.

Maxime Teisseyre et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.